scholarly journals Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

2013 ◽  
Vol 98 (3) ◽  
pp. 1154-1162 ◽  
Author(s):  
Chantal Mathieu ◽  
Priscilla Hollander ◽  
Bresta Miranda-Palma ◽  
John Cooper ◽  
Edward Franek ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Glargine ◽  
Insulin Degludec ◽  
Treat To Target ◽  
Efficacy And Safety ◽  
Target Trial ◽  
Dosing Regimen ◽  
Flexible Dosing

scholarly journals Efficacy and safety of switching from insulin glargine to insulin degludec in young people with type 1 diabetes

2016 ◽  
Vol 63 (2) ◽  
pp. 159-167 ◽  
Author(s):  
Tatsuhiko Urakami ◽  
Remi Kuwabara ◽  
Masako Aoki ◽  
Misako Okuno ◽  
Junichi Suzuki
Keyword(s):  
Type 1 Diabetes ◽  
Young People ◽  
Insulin Glargine ◽  
Insulin Degludec ◽  
Efficacy And Safety

Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1-year treat-to-target trial

2015 ◽  
Vol 18 (1) ◽  
pp. 96-99 ◽  
Author(s):  
M. Davies ◽  
T. Sasaki ◽  
J. L. Gross ◽  
G. Bantwal ◽  
Y. Ono ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Detemir ◽  
Insulin Degludec ◽  
Treat To Target ◽  
Target Trial
Sign in / Sign up

Export Citation Format

Share Document